These data strongly suggest that in colon cancer uPA-mediated plasmin-dependent serine and metalloproteolytic activity requisite for matrix degradation coinside with high uPAR expression and can be inhibited by blocking uPA/uPAR and plasmin mediated pathways. The gene discussed is PLG; the disease is colonic neoplasm.